Montalescot G - Search Results

1

Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention.

Lotrionte M, Biondi-Zoccai GG, Agostoni P, Abbate A, Angiolillo DJ, Valgimigli M, Moretti C, Meliga E, Cuisset T, Alessi MC, Montalescot G, Collet JP, Di Sciascio G, Waksman R, Testa L, Sangiorgi G, Laudito A, Trevi GP, Sheiban I. Lotrionte M, et al. Among authors: montalescot g. Am J Cardiol. 2007 Oct 15;100(8):1199-206. doi: 10.1016/j.amjcard.2007.05.048. Epub 2007 Jul 30. Am J Cardiol. 2007. PMID: 17920357 Review.

2

Endothelin-1 in patients with coronary heart disease undergoing cardiac catheterization.

Montalescot G, Viossat I, Chabrier PE, Sotirov I, Détienne JP, Drobinski G, Frank R, Grosgogeat Y, Thomas D. Montalescot G, et al. J Am Coll Cardiol. 1994 Nov 1;24(5):1236-41. doi: 10.1016/0735-1097(94)90104-x. J Am Coll Cardiol. 1994. PMID: 7930245 Free article. Clinical Trial.

3

Fibrinogen as a risk factor for coronary heart disease.

Montalescot G, Collet JP, Choussat R, Thomas D. Montalescot G, et al. Eur Heart J. 1998 Jul;19 Suppl H:H11-7. Eur Heart J. 1998. PMID: 9717059 Review.

4

Pharmacological remodeling of the thrombus architecture.

Collet JP, Montalescot G, Soria J, Mishal Z, Soria C. Collet JP, et al. Among authors: montalescot g. Blood Coagul Fibrinolysis. 1999 Feb;10 Suppl 1:S49-53. Blood Coagul Fibrinolysis. 1999. PMID: 10070819 Review. No abstract available.

5

Acute myocarditis presenting as acute myocardial infarction and sudden death with complete atrioventricular block: value of antimyosin scintigraphy.

Vilain D, Collet JP, Sarda L, Choussat R, Montalescot G, Le Guludec D, Faraggi M. Vilain D, et al. Among authors: montalescot g. J Nucl Cardiol. 1999 Sep-Oct;6(5):547-8. doi: 10.1016/s1071-3581(99)90028-4. J Nucl Cardiol. 1999. PMID: 10548151 No abstract available.

6

[Antithrombotics and interventional cardiology].

Collet JP, Montalescot G. Collet JP, et al. Among authors: montalescot g. Arch Mal Coeur Vaiss. 1999 Nov;92(11 Suppl):1667-79. Arch Mal Coeur Vaiss. 1999. PMID: 10598250 Review. French.

7

Low molecular weight heparin after mechanical heart valve replacement.

Montalescot G, Polle V, Collet JP, Leprince P, Bellanger A, Gandjbakhch I, Thomas D. Montalescot G, et al. Circulation. 2000 Mar 14;101(10):1083-6. doi: 10.1161/01.cir.101.10.1083. Circulation. 2000. PMID: 10715251 Clinical Trial.

8

A rise of troponin and/or von Willebrand factor over the first 48 h is associated with a poorer 1-year outcome in unstable angina patients.

Montalescot G, Collet JP, Choussat R, Ankri A, Thomas D. Montalescot G, et al. Int J Cardiol. 2000 Feb 15;72(3):293-4. doi: 10.1016/s0167-5273(99)00202-8. Int J Cardiol. 2000. PMID: 10716143 Clinical Trial. No abstract available.

9

Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina.

Montalescot G, Collet JP, Lison L, Choussat R, Ankri A, Vicaut E, Perlemuter K, Philippe F, Drobinski G, Thomas D. Montalescot G, et al. J Am Coll Cardiol. 2000 Jul;36(1):110-4. doi: 10.1016/s0735-1097(00)00695-1. J Am Coll Cardiol. 2000. PMID: 10898421 Free article. Clinical Trial.

10

Effect of prior exposure to Chlamydia pneumoniae, Helicobacter pylori, or cytomegalovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction.

Choussat R, Montalescot G, Collet J, Jardel C, Ankri A, Fillet A, Thomas D, Raymond J, Bastard J, Drobinski G, Orfila J, Agut H, Thomas D. Choussat R, et al. Among authors: montalescot g. Am J Cardiol. 2000 Aug 15;86(4):379-84. doi: 10.1016/s0002-9149(00)00950-4. Am J Cardiol. 2000. PMID: 10946028

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

811 results

Search Page

Filters